ANGO vs ROL · rev $292.5M vs P/E 41, rev $3.39B
AngioDynamics Inc (ANGO) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ANGO currently screens at market cap $378.5M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ANGO and ROL stock pages for the full models.
Not investment advice.